Skip to main content
. 2021 Oct 27;12(11):1010. doi: 10.1038/s41419-021-04204-7

Fig. 6. Hepatocyte-derived EV treatment reduced CCR2, CCR8, and CCR9 expression in BM cells.

Fig. 6

A CCR2, CCR8, and CCR9 mRNAs in BM cells 12 h after HepG2-EVs or PXB-EVs addition into culture supernatant were measured via real-time (RT-qPCR), and each sample was normalized relative to β-actin expression. Data represent the mean ± SD of triplicate experiments. B CCR2, CCR8, and CCR9 mRNA in BM cells collected from mice 48 h after injection of CCL4 + PBS or CCL4 + PXB-EVs were quantified using RT-qPCR. β-actin was used as an internal control. Data represent the mean ± SD of triplicate experiments. Statistical analysis was performed using one-way ANOVA and subsequent Tukey’s HSD method or student’s t test. *P < 0.05, **P < 0.01.